日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines

理清棘手问题:新冠肺炎后及接种mRNA新冠疫苗后发生的心肌炎和心包炎

Rafaniello, Concetta; Gaio, Mario; Zinzi, Alessia; Sullo, Maria Giuseppa; Liguori, Valerio; Ferraro, Marialuisa; Petronzelli, Fiorella; Felicetti, Patrizia; Marchione, Pasquale; Marra, Anna Rosa; Rossi, Francesco; De Angelis, Antonella; Capuano, Annalisa

Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy

Tenatumomab 对 T 细胞非霍奇金淋巴瘤中 Tenascin-C 的评估确定了放射免疫治疗的新靶点

Gritti, Giuseppe; Gianatti, Andrea; Petronzelli, Fiorella; De Santis, Rita; Pavoni, Chiara; Rossi, Riccardo Lorenzo; Cattaneo, Laura; Spagnoli, Luigi Giusto; Ferrari, Silvia; Rossi, Andrea; Barbui, Anna Maria; Rambaldi, Alessandro

Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.

利用工程化学修饰抗体 DN30 抑制 Met 致癌受体的配体非依赖性组成型激活

Vigna Elisa, Chiriaco Cristina, Cignetto Simona, Fontani Lara, Basilico Cristina, Petronzelli Fiorella, Comoglio Paolo M

Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody.

单价性释放了 DN-30 抗 Met 抗体的全部治疗潜力

Pacchiana Giovanni, Chiriaco Cristina, Stella Maria C, Petronzelli Fiorella, De Santis Rita, Galluzzo Maria, Carminati Paolo, Comoglio Paolo M, Michieli Paolo, Vigna Elisa

OXavidin for tissue targeting biotinylated therapeutics

用于组织靶向生物素化治疗的OXavidin

De Santis, Rita; Albertoni, Claudio; Rosi, Antonio; Leoni, Barbara; Petronzelli, Fiorella; D'Alessio, Valeria; Nucera, Eleonora; Salvatori, Giovanni; Paganelli, Giovanni; Verdoliva, Antonio; Carminati, Paolo; Nuzzolo, Carlo Antonio